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A B S T R A C T
Breast cancer is the most common tumor affecting women worldwide. Breast-conserving therapy (BCT)
followed by irradiation nowadays is the treatment of choice for early-stage disease; there is no difference
in long-term survival betweenmastectomy and BCT combined with external radiotherapy. A positive margin
is associatedwith increased risk of local recurrences after BCT for invasive breast cancer and ductal carcinoma
in situ. The exact deﬁnition of an adequate surgicalmargin after breast cancer resection has long beendebated
among physicians and represents an area of considerable variation in clinical practice. There is a lack of
standardization in the pathologymethods ofmargin evaluation, which yields little consensus regardingwhat
constitutes an adequate negative margin. As a consequence, patient management varies widely based on the
threshold that surgeons accept for adequate margins and the subsequent need for re-excision. We analyze
and discuss recent literature about this topic both from the pathological and from the surgical point of view.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Breast cancer is the most common tumor affecting women world-
wide; in Italy about 41,000 new breast cancers are diagnosed yearly. 1
The adoption of screeningmammography has led to the identiﬁcation
of smaller, often non-palpable, tumors that can be treated with
breast-conserving surgical approaches as opposed tomastectomy. 2–4
Breast-conserving therapy (BCT) followed by irradiation nowadays is
the treatment of choice for early-stage disease; there is no difference
in long-term survival (more than 20 years) between mastectomy and
BCT combined with external radiotherapy. 5,6 The main goal of BCT
is the complete removal of cancer with clear surgical margins while
maintaining the natural shape of the breast. The principal risk with
the conservative option is local recurrence, ranging between 0.6% and
1.5% per year, and is directly related to the presence of residual tumor
in the remaining mammary gland, since isolated local recurrence
(i.e. without systemic metastases) is mainly observed in the ﬁrst
2–3 years after surgery. 7 Re-excision is a possible further procedure
in women undergoing BCT in order to obtain negative margins in
patients with initial positivemargins. Recent reports have shown that
oncoplastic surgery (OPS) was effective in reducing re-excision rate
for positive margins in invasive ductal carcinoma (IDC) and ductal
carcinoma in situ (DCIS). 8,9 OPS is deﬁned by the combination of
surgical oncology principleswith plastic surgery techniques, allowing
larger excision of breast tissue compared to standard BCT for the
treatment of patients with DCIS and IDC.
The status of the surgical margins is assessed by applying ink
to the surface of the lumpectomy specimen and determining the
microscopic distance between tumor cells and the inked surface. The
exact deﬁnition of an adequate surgical margin after breast cancer
resection has long been debated among physicians and represents an
area of considerable variation in clinical practice. 10–12
2. Pathological evaluation
There is no standard method of margin evaluation for breast
specimens and there is no standard number of histologic sections
examined from each margin surface. Margins can be evaluated
(a) by a radial method, (b) by a shaved method, or (c) by shaving the
walls of the lumpectomy cavity.
a. The most common method of margin assessment is the radial
(or perpendicular) margin technique, which allows for a precise
measurement of the distance from the tumor to the inked margin.
With this method the specimen is received with at least two of
the margins marked with metal clips or sutures for specimen
orientation. The six margins of the specimen are then inked in
six different colors by the prosector. The inked breast tissue is cut
into 0.2–0.3 cm sequential sections perpendicular to its long axis so
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that the perimeter of each tissue section contains few (two to four)
margins identiﬁed by the different ink colors. With this technique
the pathologist can report the exact microscopic distance from the
tumor to each margin and can distinguish between a truly positive
margin (tumor at ink) and a close margin. The disadvantages of
thismethod include running ink, imprecisemargin orientation and
surface complexity of the breast specimen.
b. The use of shaved (en face ) margins allows the oriented specimen
to be inked entirely in one color, as long as the prosector is able
to maintain the proper orientation, and eliminates the problem of
different color inks running together. The margins are shaved off
parallel to the surface of the inked specimen at a tissue depth of
0.2–0.3 cm, similar to the process of peeling an orange. The sections
are then embedded en face with the inked surface facing down so
that the microscopic examination starts from the inner aspect of
the breast specimen. With this technique a margin is reported as
positive when tumor is present anywhere in the section, which
means that malignant cells may be present within a 0.2–0.3 cm
radius from the margin or at the margin, but the exact distance of
the tumor to the margin cannot be evaluated by the pathologist.
If no tumor is identiﬁed, the margin is reported as negative. The
advantages of this method include easier and faster microscopic
examination, no occurrence of ink problems and the examination
of a larger portion of the specimen’s surface with relatively few
histologic sections. The disadvantage is that this technique is
extremely problematic for surgeons since it increases the number
of margins called positive.
c. The third method, shaving the walls of the lumpectomy cavity,
provides a nice solution to margin evaluation and combines the
advantages of the radial and en face margin assessments: the
surgeon resects the index lesion and then takes separate shaved
margins from the cavity. The main breast specimen containing
the tumor is received unoriented and does not need to be
inked. Each shaved specimen represents a margin (medial, lateral,
superior, inferior and posterior walls of the cavity) and is received
oriented with a suture or metal clip designating the ﬁnal surgical
margin. The anterior margin may or may not be submitted by the
surgeon. This technique allows precise margin designation and an
accurate measurement of the margin width, and limits additional
manipulation of the breast tissue since compression devices used
for the specimen radiography may alter measurements of the
margin distances. Although an increase in the number of histologic
blocks and slides is the main concern for this method, a number of
studies report that this method reduces the rate of re-excision for
close margins. 13–19
3. Surgical margins
The possible scenarios of margin assessment encountered at the
microscope are: broadly positive margin (Fig. 1), focally positive
margin (Fig. 2), close margin (Fig. 3), negative margin (Fig. 4),
and cauterized margin (Fig. 5),. As previously mentioned, there is
a lack of standardization in the pathological methods of margin
evaluation, which yields little consensus regarding what constitutes
an adequate negative margin. Patient management varies widely
based on the threshold that surgeons accept for adequate margins
and the subsequent need for re-excision. Morrow et al. 20 recently
proposed that the negative margin used in the National Surgical
Adjuvant Breast and Bowel Project (NSABP) trials should be adopted
as the deﬁnition of an adequate margin, and the close margin, as
described by pathologists and interpreted by patients and clinicians
as evidence of inadequate surgery, should be replaced by the
Fig. 1. Positive margin: poorly differentiated invasive ductal carcinoma (large black
arrow) at ink (gray arrow) in association with high-grade ductal carcinoma in situ
(small black arrow) (H&E, 4× magniﬁcation).
Fig. 2. Focally positive margin: high-grade ductal carcinoma in situ (black arrow) at ink
(gray arrow) (H&E, 4× magniﬁcation).
Fig. 3. Close margin: high-grade ductal carcinoma in situ (large black arrow) 0.1 cm
from the inked edge, but not at ink (gray arrow); surrounding unremarkable breast
lobules (small black arrow) (H&E, 4× magniﬁcation).
measurement of the distance of the tumor from the inked resection
margin, without any additional qualiﬁcations. It is also important to
recognize that a reported negativemargin does not conﬁrm that there
is no residual tumor in the breast; rather it indicates that the residual
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Fig. 4.Negativemargin: high-grade ductal carcinoma in situ (black arrow) >0.1 cm from
the inked edge (gray arrow) (H&E, 4× magniﬁcation).
tumor burden is low enough to be likely controlled by radiotherapy.
In recognition of themultiple factors impacting local control of breast
cancer, a consensus conference concluded that the only negative
margin width for all patients with invasive carcinoma was tumor not
touching the inked margin. 21
In the case where there is an extensive intraductal component (EIC;
25% of tumor mass) in association with the invasive carcinoma it
may be more appropriate to obtain a margin of at least 0.2 cm if
large amounts of ductal carcinoma in situ (DCIS) are in proximity
to the margin, since it has been shown that 70% of low-grade
DCIS, 55% of intermediate-grade DCIS and 10% of high-grade DCIS
may grow discontinuously within the ducts. 22 Also the presence of
residual calciﬁcations at the lumpectomy site is a strong predictor of
residual DCIS and even when margins are reported negative, residual
suspicious calciﬁcations should be an indication for re-excision. 23,24
The criteria for surgical re-excision by mastectomy after BCT,
according to the Standards, Options and Recommendations (SOR)
guidelines are positive resectionmargins, the extension of intraductal
lesions extending beyond 3 cm, and the presence of multifocal
lesions. 25,26 However, according to the literature, 30–65% of mas-
tectomies performed after BCT are free of residual tumor, which
therefore casts doubt on the validity of these procedures providing
no therapeutic beneﬁt, impairing cosmesis and increasing morbidity
and costs. 27,28 In daily clinical practice it is important to know
predictors of the risk of residual cancer in the presence of positive
or close margins in order to identify patients in whom unnecessary
re-excision(s) or mastectomies could be avoided. Young age, tumor
size, nodal status, number of involved margins, multifocality and
extent of the tumoral lesion, presence of an extensive intraductal
component have been found to be associated with the risk of residual
cancer in the tumor cavity. 29–33 In any case, no predictive factor has
yet been proven to be reliable enough to exactly identify patients
with involvedmargins in whom re-excision(s) or mastectomies could
safely be omitted. However, it is also important to estabilish the
exact anatomical situation of the positive margins; the absence of
re-excision in the case of positive margins, whether anterior (close
to skin) or posterior (close to pectoral muscle), does not appear to
signiﬁcantly increase the risk of recurrence, whereas positivemargins
are a risk factor for local recurrencewhen in contactwith the remnant
gland. 34
The deﬁnition of acceptable margin width is similar for invasive
cancer and forDCISwithRT; inDCIS treatedwithout RT largermargins
are favored. The case is different for lobular carcinoma in situ (LCIS)
which is known to be a marker for breast cancer and not necessarily
a precursor. A larger recent study has shown classic LCIS near the
margin does not increase local recurrence. 10,35
Neoadjuvant chemotherapy (NACT) allows removal of a smaller
amount of breast tissue than if initial surgery was performed.
Shrinkage of the locally advanced breast tumor in response to NACT
has been shown to occur in two different ways: concentrically and
in a honeycomb or buckshot pattern. In patients with a pathologic
complete response or concentric tumor shrinkage, consideration of
margin width does not differ from that in a non-NACT setting. In
contrast, in patients with the buckshot pattern of tumor shrinkage,
determination of the appropriate extent of resection may be prob-
lematic perhaps due to the biologic features of the tumor, suggesting
that if viable residual tumor is present scattered throughout the
lumpectomy, even if it is not at the inked margin, re-excision should
be considered. 36
In patients with positivemargins, radiotherapywith a boost dose to
the tumor bed could be anoption if re-excision is likely to compromise
the cosmetic outcome or is technically not feasible.
A new technique recently proposed for intraoperative margin
assessment is optical coherence tomography (OCT) – a high-
resolution microscopic optical imaging technique that yields real-
time multidimensional images of subsurface tissue structure. 37
OCT is the optical analogue of ultrasound imaging but uses lightwaves
(a) (b)
Fig. 5. (a) Cautery artifact (large black arrow; H&E, 4× magniﬁcation) limits the interpretation of the specimen margin in relation to the in situ carcinoma (small black arrow).
(b) Cautery artifact may preclude the morphologic appreciation of the in situ ductal carcinoma (black arrow, H&E, 10× magniﬁcation).
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instead of sound waves to create images. The penetration depth in
breast tissue is about 1–2mm, making OCT a suitable technology for
intraoperative tumor margin assessment and suitable also for DCIS.
The validity of this new techniquemust be conﬁrmed by other data.
4. Conclusion
Apositivemargin is associatedwith increased risk of local recurrences
after BCT for invasive breast cancer and DCIS. There is no cut off
for the margin width, and the signiﬁcance of a close margin
remains controversial. The surgeon needs to balance the risk of local
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